Events
Seminars 1990-1994
“Molecular Genetics of the Dystroglycan Complex and Muscular Dystrophy.” McGill University, 10th F.L. McNaughton Lecturer, Montréal Neurological Institute and Hospital, Montréal, Canada, December 5-7, 1994.
“Dystroglycan: A Novel Laminin Receptor and Its Role in Muscular Dystrophy.” University of Iowa, College of Medicine, Department of Neurology, Update in Neuromuscular Disease, Iowa City, Iowa, November 5-6, 1994.
“Identification and Functional Characterization of Subunit Interaction Sites in Voltage-Gated Calcium Channels.” International Symposium, Molecular and Cell Biology of Ion Channels, Cancun, Mexico, September 30-October 3, 1994.
“Dystroglycan: A Novel Laminin/Agrin Receptor Linking Extracellular Matrix to Cytoskeleton.” Miles, Inc., New Haven, CT, September 27-29, 1994.
“Dystroglycan: A Novel Laminin Binding Protein and Its Role in Muscular Dystrophy.” University of Arizona, Tucson, Arizona, September 22, 1994.
“Role of Dystroglycan and Dystrophin-Associated Glycoproteins in Muscular Dystrophy.” Vanderbilt University Medical Center, MSTP Program, Nashville, Tennessee, November 2, 1994.
“Neuronal Ca2+ Channel Structure and Subunit Interaction Sites.” Vanderbilt University Medical Center, 1994 Lamson Memorial Lecturer, Department of Pharmacology, November 1, 1994.
“Dystroglycan: A Novel Merosin Receptor and Its Role in the Molecular Pathogenesis of Muscular Dystrophy.” and “Deficiency of Adhalin in the Cardiomyopathic Hamster: A Possible Model for Autosomal Recessive Muscular Dystrophy and Cardiomyopathy” VIII International Congress on Neuromuscular Diseases, Kyoto, Japan, July 8-16, 1994.
“Dystroglycan: A Novel Laminin Binding Protein and Its Relationship to Muscular Dystrophy.” Neuromuscular and EMG Conference, Iowa City, Iowa, June 24, 1994.
“Dystroglycan: A Novel Laminin Binding Glycoprotein of Muscle.” Gordon Research Conference, Basement Membranes, Wolfeboro, New Hampshire, June 14, 1994.
“Dystroglycan, A Novel Laminin Receptor and Its Role in Muscular Dystrophy.” University of Michigan, MAC Symposium, Detroit, Michigan, May 27, 1994.
“Identification and Functional Characterization of Subunit Interaction Sites In Voltage-Gated Ca2+ Channels.” Parke-Davis Biotechnology, Ann Arbor, Michigan, May 26, 1994.
“Identification and Functional Characterization of Subunit Interaction Sites In Voltage-Gated Ca2+ Channels.” University of Michigan, Department of Physiology, Detroit, Michigan, May 25, 1994.
“Dystroglycan, A Novel Laminin Receptor and its Role in Muscular Dystrophy.” American Society for Biochemistry and Molecular Biology, Amgen Award Presentation, Washington, D.C., May 24, 1994.
“Identification of Subunit Interaction Sites Within Ca2+ Channels.” University of Minnesota, Minneapolis, Minnesota, May 19, 1994.
“Dystroglycan: A Novel Laminin Binding Protein and Its Role in Muscular Dystrophy.” University of Minnesota, Minneapolis, Minnesota, May 18, 1994.
“Dystroglycan: A Novel Merosin Binding Protein and its Role in Muscular Dystrophy.” I.N.S.E.R.M., Paris, France, April 27, 1994.
“Calcium Channel b-Subunit Binds to a Conserved Motif in the I-II Cytoplasmic Linker of the a1 Subunit.” Bayer AG, International Albrecht Fleckenstein Award 1994 Presentation, Leverkusen, Germany, April 25, 1994.
“Dystrophin, Dystrophin-Associated Glycoproteins and Extracellular Matrix Protein.” European Neuro Muscular Center, Congenital Muscular Dystrophy International Workshop, The Netherlands, April 22-24, 1994.
“Ca2+ Channel Structure and Subunit Interaction Sites.” Mayo Clinic, Rochester, Minnesota, April 13, 1994.
“Dystroglycan: A Novel Laminin Binding Protein and Its Relationship to Muscular Dystrophy.” Mayo Clinic, Rochester, Minnesota, April 12, 1994.
“Voltage-Sensitive Ca2+ Channels: Structure and Subunit Interaction Sites.” University of Chicago, Neurobiology, Chicago, Illinois, February 17, 1994.
“Voltage-Sensitive Ca2+ Channels: Structure and Subunit Interaction Sites.” Massachusetts General Hospital, Neurosurgery, Boston, Massachusetts, January 12-13, 1994.
“Dystroglycan: A Novel Laminin-Binding Protein and Its Role in Muscular Dystrophy.” Stanford University, MSTP Program, Stanford, California, November 18, 1993.
“Voltage-Sensitive Ca2+ Channels: Structure and Subunit Interaction Sites.” University Medical Center, Stanford, California, November 17, 1993.
“Structural and functional characterization of N-type Ca2+ channels.” Calcium Channels and Neuronal Signaling Meeting, Washington, D.C., November 4-9, 1993.
“Molecular Pathogenesis of Duchenne Muscular Dystrophy.” Muscular Dystrophy Association Western Iowa Chapter, Midwest Seminar, Des Moines, Iowa, October 2, 1993.
“Possible Role of the Dystrophin-Glycoprotein Complex in Cardiomyopathy.” University of California, San Francisco, Program of Excellence in Molecular Biology Seminar, San Francisco, California, September 26-27, 1993.
“Molecular Pathogenesis of Duchenne Muscular Dystrophy.” Muscular Dystrophy Association Awareness Seminar, Moline, Illinois, September 25, 1993.
“Possible Role of Dystrophin-Glycoprotein Complex in Cardiomyopathy.” American Heart Association, Molecular Biology of the Normal, Hypertrophied and Failing Heart, Pacific Grove, California, August 4-8, 1993.
“Dystroglycan, A Novel Laminin Binding Protein and Its Role in Muscular Dystrophy.” Gordon Conference, Cell Contact and Adhesion, Andover, New Hampshire, July 1, 1993.
“Purification of w-Conotoxin Sensitive Ca2+ Channels.” Vanderbilt University, Department of Molecular Physiology & Biophysics, Nashville, Tennessee, June 17, 1993
“Molecular Pathogenesis of Duchenne Muscular Dystrophy.” Cornell University Medical College, The Department of Cell Biology and Anatomy, The Nina W. Werblow Lecture, New York, New York, May 20, 1993
“Dystroglycan and Molecular Pathogenesis of Duchenne Muscular Dystrophy.” National Institutes of Health, Bethesda, Maryland, May 29, 1993.
“Dystroglycan: A Novel Laminin Receptor.” Howard Hughes Medical Institute Annual Scientific Meeting, Receptors and Receptor Function in Health and Disease, Chevy Chase, Maryland, May 16-19, 1993.
“Dystroglycan and Molecular Pathogenesis of Duchenne Muscular Dystrophy.” The University of Texas, Southwestern Medical Center at Dallas, University of Texas Lecture Series, Dallas, Texas, April 28, 1993.
“Dystrophin and Utrophin: Functional and Comparative Aspects.” Cold Spring Harbor, Gene Reactivation as a Therapeutic Strategy for Duchenne and Becker Muscular Dystrophies, Session II: Regulation of Dystrophin and Dystrophin-Related Protein Gene Expression, New York, New York, April 26, 1993.
“Dystroglycan and Molecular Pathogenesis of Duchenne's Muscular Dystrophy.” Massachusetts General Hospital, February 23, 1993, Boston, Massachusetts
“Purification and Characterization of Conotoxin-Sensitive Calcium Channels.” Harvard Medical School, Boston, Massachusetts, February 22, 1993.
“Dystroglycan: A Novel Laminin Binding Protein and Its Role in Muscular Dystrophy.” Yale University, New Haven, CT, December 3, 1992
“Purification and Characterization of the w-Conotoxin-Sensitive Calcium Channel.” Miles Laboratories, Inc., West Haven, CT, December 3, 1992.
“Intracellular Calcium Release Channels: Structure, Function and CNS Distribution.” Society for Neuroscience, New Waves in Cell Calcium, Anaheim, California, October 27, 1992.
“Purification and Characterization of the w-Conotoxin Sensitive Calcium Channel from Rabbit Brain.” Bayer AG Seminar, Wuppertal, Germany, September 23, 1992.
“Dystroglycan: High Affinity Laminin Receptor in Skeletal Muscle.” XXI European Muscle Congress Meeting, Ion Channels and Other Membrane-Associated Proteins, Bielefeld, Germany, September 22, 1992.
“Molecular Basis for Autosomal Recessive Muscular Dystrophy: A 50 kDa Dystrophin-Associated Glycoprotein Deficiency.” Howard Hughes Medical Institute Annual Scientific Meeting, Genetic Disorders and the Search for Genetic Factors in Disease, Bethesda, Maryland, September 13-16, 1992.
“Molecular Pathogenesis of Duchenne Muscular Dystrophy.” University of Iowa and University of Minnesota, Medical Scientist Training Program Retreat, Lake Okoboji, Iowa, August 29, 1992.
“Laminin Binding Properties of Dystroglycan and its Role in Muscular Dystrophy.” University of Iowa, Physiology and Biophysics Workshop, August 26, 1992.
“Purification and Characterization of the w-Conotoxin Sensitive Calcium Channel from Rabbit Brain.” Neurex Corporation Seminar, Menlo Park, California, August 17, 1992
“The Role of the Dystrophin-Glycoprotein Complex in the Transmembrane Linkage Between Laminin and Actin.” Cold Spring Harbor Laboratory, Brain Development and Function, Cold Spring Harbor, New York, August 7, 1992.
Chairperson and Organizer, FASEB Conference on Calcium and Cell Function, Vermont Academy, Saxton Rivers, VT, July 5-10, 1992.
“Dystroglycan: Structure, Function and Its Role In the Molecular Pathogenesis of Duchenne Muscular Dystrophy.” Institut de Pathologie Moleculaire, Service de Biochimie Genetique, Pavillon Cassini, Paris, France, May 26, 1992.
“Dystroglycan: Structure, Function and Its Role In the Molecular Pathogenesis of Duchenne Muscular Dystrophy.” I.N.S.E.R.M., Paris, France, May 25, 1992.
“The Brain Ryanodine Receptor: A Caffeine-Sensitive Calcium Channels From Excitable Cells.” Calcium Club, Milan, Italy, May 22, 1992.
“Molecular Components of Voltage-Sensitive Calcium Channels From Excitable Cells.” The Emilio Trabucchi Foundation, Milan, Italy, May 21, 1992.
“Molecular Characterization of the Dystrophin-Associated Glycoproteins.” Iowa State University, Department of Biochemistry and Biophysics, April 23, 1992.
“Molecular Pathogenesis of Duchenne Muscular Dystrophy.” David Mahoney Institute of Neurological Sciences, University of Pennsylvania, The School of Medicine, November 20, 1991.
“Biochemistry of the w-Conopeptide Receptor.” Society for Neuroscience, Satellite Symposium, Neurex Corporation, November 10, 1991.
“Molecular Characterization of the Dystrophin-Associated Glycoproteins.” 8th International Congress of Human Genetics, Workshop Title: “Molecular and Cellular Biology of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy,” Washington, DC, October 6-11, 1991.
“Loss of Dystrophin-Associated Protein in Dystrophic Muscle.” Muscular Dystrophy Association, Gene Therapy Conference, Tucson, Arizona, September 27, 1991.
“Neuronal Ryanodine Receptor: A Caffeine-Sensitive Calcium Release Channel.” Howard Hughes Medical Institute Annual Scientific Meeting, Bethesda, Maryland, Signal Transduction and Its Consequences, September 22-25, 1991
“Ca2+ Channels and Dystrophin-Glycoprotein Complex.” Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland, July 8, 1991.
“Dystrophin-Glycoprotein Complex.” Charing Cross and Westminster Medical School, London, England, July 5, 1991.
“Muscle and Neuronal Ca Channels: Their Properties, Distribution and Structural Features.” ICI Agrochemicals, July 4, 1991.
“The Dystrophin-Glycoprotein Complex.” Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, England, July 3, 1991.
“Dystrophin-Associated Glycoproteins: Structure and Function.” 4th National Meeting on Neuromuscular Diseases, Montpellier, France, June 24-28, 1991.
“Dystrophin-Linked Glycoproteins in Duchenne Muscular Dystrophy.” FASEB Conferences, American Physiological Society 1991 Annual Spring Meeting, Symposium on “Cellular and Molecular Aspects of Muscle Disease,” Atlanta, Georgia, April 21-26, 1991
“Functional Aspects of Dystrophin.” Annual Biophysical Society Meeting, Contractility Subgroup Symposium, San Francisco, California, February 24, 1991.
“The Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.” Keystone Symposia on Molecular and Cellular Biology of “Gene Expression in Neuromuscular Development,” Keystone, Colorado, January 24-30, 1991.
“Dystrophin-Glycoprotein Complex and Molecular Pathogenesis of Duchenne Muscular Dystrophy.” Colorado State University, Department of Physiology, Fort Collins, Colorado, November 26, 1990.
“Dystrophin-Glycoprotein Complex and Molecular Pathogenesis of Duchenne Muscular Dystrophy.” University of Wisconsin-Madison, Department of Physiology, Madison, Wisconsin, October 15, 1990.
“Deficiency of a Dystrophin-Associated Glycoprotein in Duchenne Muscular Dystrophy.” VII International Congress on Neuromuscular Diseases, Surprise Box Session, Munich, West Germany, September 16-21, 1990.
“The Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.” National Cardiovascular Center Research Institute, Department of Molecular Physiology, Osaka, Japan, July 23, 1990.
“The Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.” Osaka University, First Department of Medicine, Division of Cardiology, Osaka, Japan, July 21, 1990.
“The Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.” Kyoto University, Department of Medicinal Chemistry, Kyoto, Japan, July 20, 1990.
“The Dystrophin-Glycoprotein Complex: Identification and Biochemical Characterization.” Uehara Memorial Foundation Symposium on Frontiers of Muscle Research, Tokyo, Japan, July 16-19, 1990.
“Identification and Characterization of the Dystrophin-Glycoprotein Complex in Normal and Dystrophic Muscle.” University of California, San Francisco, Department of Physiology, May 16, 1990.
“Structure of Calcium Channels.” AHA Conference on Structure & Function of Ion Channels in the Heart and Vascular System, Chicago, Illinois, May 8-11, 1990.
“Molecular Pathogenesis of Muscular Dystrophy.” Johns Hopkins University School of Medicine, Neuroscience Department, March 29, 1990.
“Molecular Pathogenesis of Muscular Dystrophy.” Howard Hughes Medical Institute Annual Scientific Meeting, Molecular Basis of Human Diseases and Animal Models of Human Disease, Bethesda, Maryland, February 11-14, 1990.
